CXCR5 and myalgic encephalomeyelitis/chronic fatigue syndrome: As shown in Figure 3, A and B, treatment of cells with FST plus serum from patients with ME/CFS for 3 days resulted in a significant decrease in the frequency of PD-1+CXCR5+ cells compared with cells treated with ME/CFS serum alone.